Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Mr. Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Kwame Nkrumah University of Science and Technology, Ghana

Stephen Twumasi is an emerging biomedical researcher with a strong academic background in haematology and medical diagnostics. His academic and professional pursuits have been shaped by a passion for understanding the molecular and immunological mechanisms underlying human diseases, particularly in the context of cancer, infectious diseases, and hematological disorders. With an M.Phil. in Haematology from Kwame Nkrumah University of Science and Technology (KNUST), Ghana, and a B.Sc. in Medical Laboratory Science from the University of Cape Coast, he has demonstrated academic rigor and a deep interest in advancing health research. Stephen has actively pursued professional development through short courses in genomics, bioinformatics, systematic reviews, and community health entrepreneurship. His current research focuses on tumor immunology, developmental hematopoiesis, and molecular diagnostics for chronic and infectious diseases. Despite being in the early stages of his research career, he is keenly aware of the global health landscape and has aligned his work with critical health issues affecting Africa and beyond. With aspirations to make a meaningful contribution to global health research, Stephen combines his academic strength with continuous skill enhancement and a commitment to multidisciplinary inquiry.

Professional Profile

Education

Stephen Twumasi’s academic journey reflects a consistent focus on biomedical sciences and a deepening specialization in haematology. He earned his M.Phil. in Haematology from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 2024. With a cumulative weighted average of 69.40/100 (equivalent to a CGPA of 3.8/4.0) and a thesis graded ‘A’ (Pass), he displayed academic excellence and research capability in the program. Prior to his postgraduate studies, he obtained a Bachelor of Science in Medical Laboratory Science from the University of Cape Coast in 2020, graduating with a Second Class Honors (Upper Division) and a CGPA of 3.2/4.0. His foundational education began at Adventist Senior High School in Kumasi, where he completed his West Africa Senior School Certificate Examination (WASSCE) in 2015. In addition to formal education, Stephen has completed several short courses to broaden his knowledge and research skills. These include certifications in Genomics and Bioinformatics, Systematic Review and Meta-analyses, Research Writing for Publication, One Health Basics, and Community Health Entrepreneurship. His commitment to lifelong learning and interdisciplinary training places him in a strong position for advanced research and academic engagement.

Professional Experience

Stephen Twumasi’s professional experience is grounded in his academic training in medical diagnostics and laboratory science. While specific employment roles have not been listed, it is evident that his academic journey included substantial practical exposure and laboratory-based research, particularly during his M.Phil. studies in Haematology. His postgraduate thesis work required advanced skills in diagnostic hematology, interpretation of immunological markers, and laboratory-based experimentation, reflecting real-world clinical and research competence. Through his involvement in academic programs and training workshops, Stephen has gained experience in handling molecular biology protocols, data analysis, and diagnostic procedures that are critical in modern healthcare settings. His training in community health entrepreneurship also suggests a practical understanding of the healthcare ecosystem and how scientific research can be translated into community impact. Stephen’s practical experience is further enhanced by his completion of skill-based short courses offered by reputable institutions and international collaborators. These programs have allowed him to interact with health researchers across Africa and beyond, enriching his perspectives and research readiness. Though his formal professional roles may still be developing, Stephen has built a strong foundation in biomedical practice and research through hands-on learning and academic immersion.

Research Interest

Stephen Twumasi’s research interests are firmly anchored in immunology, hematology, and molecular diagnostics, with a multidisciplinary approach that reflects current global biomedical priorities. He is particularly interested in understanding the immunological and molecular changes that occur within the tumor microenvironment and how these changes influence cancer progression, therapeutic response, and disease outcome. His interest also extends to developmental hematopoiesis and the molecular mechanisms that underlie blood cell formation, which are critical in understanding both normal physiology and disease pathology. Stephen aims to explore immunological and molecular cell alterations in age-related and inflammatory diseases, such as autoimmune disorders, chronic infections, and degenerative conditions. A significant portion of his research is directed at identifying early diagnostic biomarkers for diseases prevalent in sub-Saharan Africa, including HIV/AIDS, tuberculosis, sickle cell disease, diabetes, and kidney disease. This demonstrates his commitment to applied biomedical research that has direct implications for public health and clinical practice. By focusing on early detection and molecular profiling, Stephen envisions contributing to the development of cost-effective and scalable diagnostic tools. His research orientation is not only academically relevant but also aligned with global health equity and the fight against non-communicable and infectious diseases.

Research Skills

Stephen Twumasi has developed a strong portfolio of research skills that align with modern biomedical research demands. His training in haematology and molecular biology equips him with the ability to conduct detailed laboratory analyses and interpret complex immunological data. He is proficient in diagnostic techniques related to blood disorders and has applied this expertise during his thesis research and laboratory coursework. His skills extend into bioinformatics and genomics, where he has gained practical knowledge through certified training programs. Stephen is also trained in systematic reviews and meta-analysis, enabling him to conduct high-level literature synthesis and evidence-based assessments. His familiarity with research writing and publication, gained through specialized workshops, enhances his ability to produce and disseminate scientific findings effectively. Stephen is knowledgeable in One Health approaches, showing his capacity to conduct interdisciplinary research that bridges human, animal, and environmental health. His training in community health entrepreneurship complements his scientific skills by adding a dimension of translational research and innovation. Overall, Stephen possesses a diverse set of skills—ranging from laboratory diagnostics to scientific writing and data interpretation—that prepare him for successful academic research and collaborative scientific work.

Awards and Honors

While there are no specific awards or honors listed in Stephen Twumasi’s current profile, his academic achievements and certifications reflect commendable performance and initiative. His excellent academic record, especially his strong performance in the M.Phil. Haematology program at KNUST, suggests merit-worthy scholarly effort. His pursuit of numerous competitive and high-impact short courses—offered by organizations such as the German-West Africa Center for Global Health, MasterCard Foundation, and Genomac Institute—also highlights his selection into esteemed training programs. These certifications are often reserved for promising young researchers who demonstrate a commitment to academic and research excellence. In addition, Stephen has shown proactive engagement in international and interdisciplinary learning environments, which is itself a testament to his academic motivation and research potential. As his research career progresses and he begins to publish his work and engage in more collaborative projects, he is likely to attract competitive fellowships, grants, and awards. While he may currently be at the formative stage of his academic recognition, Stephen’s trajectory and research readiness point toward future honors and distinctions as he contributes more substantively to the scientific community.

Conclusion

Stephen Twumasi is a dedicated and promising early-career researcher whose academic focus and professional development align with global health and biomedical priorities. With a robust educational foundation in haematology and medical laboratory science, complemented by strategic certifications in genomics, bioinformatics, One Health, and research writing, he has cultivated a multidisciplinary research profile. His interests in tumor immunology, hematopoiesis, and early diagnostics of infectious and chronic diseases reflect a strong commitment to improving health outcomes through science. While his formal professional roles and recognitions are still evolving, his proactive learning approach and research enthusiasm position him as a future leader in biomedical research. He has already demonstrated the capacity for scientific inquiry and critical analysis, supported by practical lab experience and theoretical understanding. With continued mentorship, opportunities for publication, and engagement in collaborative research, Stephen is well on the path to making impactful contributions to medical science and public health. He is a suitable candidate for research-focused awards and development programs, and his future holds promise as he builds on his strengths and expands his academic influence. His dedication to advancing diagnostic and molecular research makes him a valuable asset to the scientific and health communities.

Publications Top Notes

  1. Haemato‐urological profile and asymptomatic urinary tract infection in Ghanaian steady‐state sickle cell disease patients: A case‐control study
    📚 Health Science Reports
    📅 Year: 2025
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien‐Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah‐Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.
    📈 Citations: Not available yet

  2. Assessing liver and iron markers in steady state paediatric SCD patients to ascertain the hepatic consequences of haemotransfusion: A case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: John Agyemang Sah, Benedict Sackey, Enoch Odame Anto, Allwell Adofo Ayirebi, Stephen Twumasi, Richard Vikpebah Duneeh, Ebenezer Senu, Veronica Barnor, David Boakye, Daniel Nii Martey Antonio, et al.

  3. Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien-Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah-Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.

  4. Diagnostic value of neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus individuals with reduced estimated glomerular filtration rate (eGFR): A case-control study in a municipal hospital in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Benedict Sackey, Lilian Antwi-Boateng, Prince Adoba, Patrick Adu, Joseph Boachie, Stephen Twumasi, Joseph Frimpong, Emmanuel Ekow Korsah, et al.

  5. Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Enoch Odame Anto, Christian Obirikorang, Richard Kobina Dadzie Ephraim, Benedict Sackey, Vivian Paintsil, Richard Owusu Ansah, Alfred Effah, Allwell Adofo Ayirebi, Angela Opoku, et al.

 

Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Dr. Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Guangdong Cardiovascular Institute, China

Dr. Hui-Qiang Wei is a dedicated clinical researcher and medical doctor specializing in cardiac electrophysiology. Currently affiliated with the Arrhythmia Center at the Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, and Southern Medical University in Guangzhou, China, Dr. Wei has built a focused and impactful career in the management and ablation of complex cardiac arrhythmias. Born in June 1990, he has steadily advanced through rigorous academic and clinical training in cardiology, with specific attention to electrophysiological interventions. Dr. Wei’s work spans both academic research and clinical practice, with a strong emphasis on catheter ablation techniques, including those involving atrial fibrillation, supraventricular tachycardias, and ventricular arrhythmias. He has contributed to multiple peer-reviewed publications in high-impact journals, and his findings have improved the understanding and procedural outcomes of cryoballoon and substrate-based ablation methods. Additionally, Dr. Wei has engaged in international collaboration through observership at the University of Pennsylvania, further enriching his perspective and methodology. His dedication to electrophysiology, growing publication record, and translational clinical research make him an emerging leader in the field. With both depth and breadth of experience, Dr. Wei exemplifies the qualities of a promising young researcher and is well-suited for consideration in prestigious research awards.

Professional Profile

Education

Dr. Hui-Qiang Wei’s educational background is firmly rooted in the cardiovascular sciences, with a particular focus on electrophysiology. He began his medical education at Southern Medical University in Guangzhou, China, where he earned his M.D. in 2013. Demonstrating an early interest in cardiology, he continued with a Master’s degree in Electrophysiology from the Guangdong Cardiovascular Institute under the mentorship of Professor Silin Chen, completing the program in 2016. Furthering his specialization, Dr. Wei pursued his Ph.D. at Fuwai Hospital, a premier cardiovascular center in Beijing, under the guidance of Professor Jian Ma. He completed his doctoral degree in 2019, focusing on advanced electrophysiological diagnostics and interventions. His academic journey has been marked by consistency, a commitment to specialization, and mentorship under leading figures in Chinese cardiovascular medicine. Additionally, he broadened his academic exposure with a visiting observership at the Hospital of the University of Pennsylvania in 2018, where he gained valuable insights into global standards in arrhythmia management and research methodology. Dr. Wei’s education has provided him with a strong theoretical foundation, clinical training, and exposure to both national and international best practices in cardiac electrophysiology.

Professional Experience

Dr. Hui-Qiang Wei has cultivated a professional career that seamlessly integrates clinical excellence with high-quality research in cardiac electrophysiology. Since 2019, he has been a part of the Guangdong Cardiovascular Institute at Guangdong Provincial People’s Hospital, a prominent center for cardiovascular care and research. In his current role at the Arrhythmia Center, he is actively engaged in both clinical procedures and research initiatives, particularly focusing on catheter-based interventions for complex arrhythmias. Prior to this position, he completed significant training and clinical work during his master’s and doctoral programs, contributing to studies in ablation therapy under the mentorship of renowned electrophysiologists. His brief but impactful time as a visiting observer at the Hospital of the University of Pennsylvania in 2018 allowed him to observe state-of-the-art procedures and academic protocols at a world-class institution. Throughout his career, Dr. Wei has performed numerous complex arrhythmia interventions and has collaborated on multi-center studies examining the efficacy and safety of various ablation technologies. His practical experience has been reinforced by continuous involvement in academic writing and presentations, bridging the gap between clinical innovation and scholarly contribution. This dual focus on practice and research underscores his professional strength and growth trajectory in cardiac electrophysiology.

Research Interest

Dr. Hui-Qiang Wei’s primary research interest lies in the field of cardiac electrophysiology, with a specialized focus on the diagnosis and interventional management of complex cardiac arrhythmias. His research has primarily explored catheter ablation techniques, including pulmonary vein isolation, ventricular tachycardia ablation, and the use of cryoballoon ablation in varied anatomical and clinical contexts. Dr. Wei is particularly interested in understanding the electrophysiological characteristics of arrhythmogenic substrates and developing strategies to improve the precision and safety of ablation therapies. His work investigates both traditional and emerging technologies, such as second-generation cryoballoon catheters, and their application in clinical and experimental settings. Additionally, he has contributed to comparative studies assessing different ablation strategies for left posterior fascicular ventricular tachycardia, and has examined long-term outcomes in substrate-based interventions. The translational nature of his research—applying physiological insights to improve procedural outcomes—marks a significant contribution to the field. Dr. Wei’s continued interest in refining ablation protocols and identifying predictors of arrhythmia recurrence aligns with global efforts to enhance the effectiveness of interventional electrophysiology and reduce procedural risks for patients.

Research Skills

Dr. Hui-Qiang Wei possesses a wide range of research skills that support his work as a clinical scientist in the domain of cardiac electrophysiology. He is proficient in designing and executing both clinical and experimental studies, including prospective and retrospective data analyses focused on catheter ablation outcomes. His experience includes electrophysiological mapping, real-time potential recording, and advanced imaging techniques used to guide and evaluate ablation procedures. Dr. Wei has also demonstrated competence in using animal models to investigate the safety and efficacy of ablation tools, as evidenced by his co-authored study on cryoballoon ablation in a canine model. His familiarity with statistical analysis and medical software allows him to handle complex datasets, ensuring the reliability and validity of his findings. Furthermore, his involvement in multi-center studies and collaborations with prominent researchers, such as Dr. Jian Ma and Dr. Jackson J. Liang, reflects his ability to work within diverse research teams. Dr. Wei is adept at translating clinical observations into research hypotheses and subsequently testing them through structured protocols. His clear scientific writing, ability to present findings at international conferences, and continuous engagement in peer-reviewed publication demonstrate strong communication and dissemination skills essential for academic medicine.

Awards and Honors

While no specific individual awards have been listed in the provided data, Dr. Hui-Qiang Wei’s professional trajectory reflects recognition through academic appointments, publication credits, and invited presentations that signal growing acknowledgment within the scientific and clinical community. Notably, he was selected for an oral presentation at the Asia Pacific Heart Rhythm Society (APHRS) 2017 conference, which is a respected forum for cardiac electrophysiologists in the Asia-Pacific region. His collaborative work has been published in leading cardiology journals such as Heart Rhythm, Europace, and Journal of Cardiovascular Electrophysiology, indicating the high quality and relevance of his research. Being first author or co-author on such impactful studies suggests trust and esteem from his mentors and research collaborators. His visiting observer role at the Hospital of the University of Pennsylvania also highlights academic merit, as such opportunities are typically offered to promising researchers with demonstrable academic potential. Although explicit awards or honors are not detailed, Dr. Wei’s academic output and the caliber of his institutional affiliations imply ongoing professional recognition and the potential for future accolades in his field.

Conclusion

Dr. Hui-Qiang Wei exemplifies the qualities of a dedicated and capable young researcher whose contributions to cardiac electrophysiology are both meaningful and steadily expanding. His focused academic background, hands-on clinical experience, and a growing portfolio of peer-reviewed publications position him as an emerging leader in arrhythmia research and intervention. He demonstrates a clear understanding of current challenges in the field and actively works toward improving procedural safety and efficacy through data-driven methods. His commitment to both research and patient care, reinforced by international exposure and collaboration, reflects a balanced professional maturity that is commendable for a researcher of his career stage. With continued development in research leadership, grant participation, and broader dissemination of his work, Dr. Wei is likely to make substantial long-term contributions to cardiovascular medicine. His background, experience, and vision align well with the purpose of the Young Researcher Award, making him a strong candidate deserving of recognition. As he continues to evolve in his academic and clinical endeavors, Dr. Wei is poised to become an influential figure in advancing electrophysiological practice and research both in China and internationally.

Publication Top Notes

  1. Association between age at diagnosis of atrial fibrillation and subsequent risk of ischemic stroke
    Authors: Y. Cheng, H. Deng, H. Wei, Y. Xue, Z. Wu
    Journal: Journal of the American Heart Association
    Year: 2025

  2. A giant left atrial appendage aneurysm with incessant atrial tachycardia
    Authors: H. Wei, Y. Xue, S. Wu, H. Liao
    Journal: Journal of Cardiovascular Electrophysiology
    Year: 2025

  3. A novel mutation in hERG gene associated with azithromycin-induced acquired long QT syndrome
    Authors: Y. Cheng, Y. Wu, H. Wei, L. Liu, W. Bi
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 1

 

Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Dr. Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China

Dr. Kandi Zhang is an emerging medical researcher and clinician specializing in internal medicine with a primary focus on cardiology. Born in September 1993, she is currently affiliated with the Department of Cardiology at Shanghai Ninth People’s Hospital, which is part of Shanghai Jiao Tong University School of Medicine, one of China’s most prestigious institutions. Her clinical and research work reflects a strong dedication to advancing diagnostic and therapeutic methods for cardiovascular diseases, particularly through innovative applications of imaging technologies, antiplatelet therapies, and proteomic biomarker analysis. She has authored several peer-reviewed publications that explore the clinical and molecular aspects of acute coronary syndrome and myocardial infarction. Dr. Zhang’s combination of academic rigor and hands-on clinical expertise has allowed her to contribute meaningful insights to the field. Her collaborations with interdisciplinary teams and consistent publication in high-quality journals suggest a trajectory toward leadership in cardiovascular medicine. With a commitment to both patient-centered care and scientific discovery, she bridges the gap between medical innovation and clinical practice, positioning herself as a key contributor to the future of life sciences research in cardiology.

Professional Profile

Education

Dr. Kandi Zhang holds a Doctorate in Internal Medicine, earned through advanced medical education and research training at the Shanghai Jiao Tong University School of Medicine. This institution is internationally recognized for its rigorous curriculum, cutting-edge medical technology, and high-impact research environment. Her academic background provided her with comprehensive knowledge in physiology, pathology, pharmacology, and advanced clinical methodologies, with a particular concentration in cardiovascular medicine. During her doctoral studies, Dr. Zhang received mentorship from leading cardiologists and participated in clinical rotations and research initiatives at Shanghai Ninth People’s Hospital. The combination of theoretical education and practical exposure enabled her to specialize in both diagnosis and treatment of complex cardiac conditions. Her doctoral research likely involved extensive literature reviews, experimental design, clinical data analysis, and application of medical imaging and laboratory techniques. This educational foundation established her competence in evidence-based medicine, advanced diagnostics, and translational research. Through this training, she cultivated the analytical, technical, and clinical judgment skills required to contribute effectively to medical science. Her continuous engagement in academic publishing indicates that she has maintained a strong scholarly presence beyond her formal education, enriching her academic qualifications with real-world impact.

Professional Experience

Dr. Kandi Zhang’s professional experience is rooted in her role at the Department of Cardiology, Shanghai Ninth People’s Hospital, a highly respected clinical and research institution in China. As a practicing cardiologist and medical researcher, she is actively involved in both patient care and scientific inquiry. Her responsibilities include diagnosing and managing cardiovascular disorders, performing and interpreting diagnostic imaging, and participating in interdisciplinary case consultations. In parallel, she conducts clinical research with a focus on cardiovascular interventions, such as myocardial infarction management without reperfusion, left atrial appendage closure procedures, and the use of proteomic platforms to analyze biomarkers in acute coronary syndrome. Her position allows her to translate bedside observations into research hypotheses, bridging clinical care with data-driven innovation. Additionally, Dr. Zhang collaborates with colleagues across departments and institutions, contributing to multi-author research papers and bringing new insights to existing cardiology practices. Her dual engagement in research and clinical services provides a unique advantage, allowing her to contribute to real-time advancements in treatment protocols. This experience has also enhanced her leadership capabilities in conducting clinical trials, publishing scientific findings, and shaping evidence-based medical practices, making her a valuable contributor to both national and international cardiology communities.

Research Interest

Dr. Kandi Zhang’s research interests lie at the intersection of clinical cardiology, cardiovascular imaging, and molecular biomarker discovery. Her scholarly pursuits focus on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions, including myocardial infarction, atrial fibrillation, and acute coronary syndrome. She is particularly interested in the pre-treatment efficacy of antiplatelet medications in non-reperfused myocardial infarction cases, a subject with significant implications for emergency cardiac care. Another key area of her research involves comparative studies of imaging modalities for left atrial appendage closure—an essential technique for stroke prevention in atrial fibrillation patients. Her recent work has expanded into proteomics, exploring biomarker signatures in young patients with acute coronary syndrome, which opens possibilities for personalized medicine and early detection strategies. Dr. Zhang is committed to translational research that can swiftly impact clinical decision-making. By integrating data from various sources—including imaging, clinical trials, and molecular assays—her work advances the precision and effectiveness of cardiac interventions. She aspires to contribute to the development of non-invasive, cost-effective, and scalable diagnostics for cardiovascular diseases. Her research interests reflect a broader vision of integrating technology, biology, and clinical medicine to address pressing challenges in heart health globally.

Research Skills

Dr. Kandi Zhang possesses a robust set of research skills that complement her clinical expertise. Her methodological proficiency spans clinical trial design, statistical analysis, medical imaging evaluation, and biomarker identification using proteomics. She is adept at using various imaging techniques to support therapeutic interventions, as evidenced by her publication on evaluating orifice diameters for atrial appendage closure. Her familiarity with experimental protocols, animal models, and in vitro assays—such as her work on myocardial infarction in mice—demonstrates her versatility in both basic and applied research. She also shows skill in bioinformatics and data interpretation, especially in translating proteomic findings into clinically relevant insights. Furthermore, she has strong experience in scholarly writing, data visualization, and peer-reviewed publishing, which are essential for knowledge dissemination and academic contribution. Her ability to work collaboratively on multi-author projects highlights her communication and teamwork skills, crucial for multidisciplinary research environments. Dr. Zhang is also proficient in integrating patient data with clinical outcomes, allowing for a nuanced understanding of treatment efficacy. These research skills enable her to contribute to innovative, evidence-based practices in cardiology, and position her as a strong candidate for collaborative projects across the life sciences and medical research domains.

Awards and Honors

While specific named awards are not explicitly listed in the available profile, Dr. Kandi Zhang’s consistent publication in high-impact, peer-reviewed journals and affiliation with a top medical university suggest academic excellence and institutional recognition. Being a first or lead author in multiple scientific papers published in journals such as Cardiology Journal, Clinical Cardiology, and Frontiers in Cardiovascular Medicine indicates that her work is well-regarded within the cardiology and life sciences communities. Such scholarly visibility often accompanies internal honors such as best researcher accolades, conference recognitions, or research funding awards within the academic medical network. Her role at Shanghai Ninth People’s Hospital—a center for high-level research and patient care—also implies that she has undergone competitive selection processes and met stringent performance standards. Moreover, her early-career contributions, particularly in bridging clinical and molecular research, may position her for future international awards in cardiovascular research and life sciences innovation. If she continues on this trajectory, it is likely that formal recognitions and honors will follow as her influence in the field expands.

Conclusion

Dr. Kandi Zhang exemplifies the qualities of an innovative and impactful researcher in the field of life sciences, particularly in cardiovascular medicine. Through a combination of clinical practice, rigorous academic training, and a solid research portfolio, she has established herself as a credible and forward-thinking contributor to cardiology. Her studies on antiplatelet drug efficacy, imaging modality optimization, and proteomics-based biomarker identification highlight her commitment to solving real-world health challenges through science. While her profile would benefit from broader international exposure and interdisciplinary collaboration, her current achievements mark her as a rising figure in translational cardiovascular research. With continued effort and strategic partnerships, she is well-positioned to lead impactful projects that could redefine patient care standards in cardiology. As she advances in her career, Dr. Zhang has the potential to influence both academic and clinical landscapes, making her a strong candidate for recognition through life sciences innovation awards and future leadership roles in global medical research.

Publications Top Notes

  • Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events

    • Authors: Kandi Zhang, Hanwen Yu, Yihua Lu, Peng Zhang, Dongsheng Liu, Jianpeng Huang, Jing Zhou, Yiqian Yuan, Zongqi Zhang, Qingyong Zhang et al.

    • Year: 2025

  • Clinical Characteristics and Biomarkers Feature Analysis Using a Proteomics Platform in Young Patients with Acute Coronary Syndrome

    • Authors: Zhang K, Wang F, Yu Q, Song Y, Gu J, He Q, Zhang J

    • Year: 2024

  • Angiopoietin-like Protein 2 Inhibits Thrombus Formation

    • Authors: Zhang T, Zhang M, Guo L, Liu D, Zhang K, Bi C, Zhang P, Wang J, Fan Y, He Q et al.

    • Year: 2024

  • Identification of Shared Molecular Mechanisms and Diagnostic Biomarkers Between Heart Failure and Idiopathic Pulmonary Fibrosis

    • Authors: Zhang P, Geng L, Zhang K, Liu D, Wei M, Jiang Z, Lu Y, Zhang T, Chen J, Zhang J

    • Year: 2024

  • AGK Potentiates Arterial Thrombosis by Affecting Talin-1 and αIIbβ3-Mediated Bidirectional Signaling Pathway

    • Authors: Zhang P, Jiang H, Yang M, Bi C, Zhang K, Liu D, Wei M, Jiang Z, Keyu Lv, Fang C et al.

    • Year: 2023

  • Role of GPR56 in Platelet Activation and Arterial Thrombosis

    • Authors: Liu D, Zhang P, Zhang K, Bi C, Li L, Xu Y, Zhang T, Zhang J

    • Year: 2022

  • Comparison of Multiple Imaging Modalities for Measuring Orifice Diameter and Selecting Occluder Size in Patients Undergoing Left Atrial Appendage Closure

    • Authors: Kandi Zhang, Jing Zhou, Tiantian Zhang, Zongqi Zhang, Shanliang Jin, Qing He, Junfeng Zhang

    • Year: 2022

  • Pretreatment with Antiplatelet Drugs Improves the Cardiac Function After Myocardial Infarction Without Reperfusion in a Mouse Model

    • Authors: Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J

    • Year: 2019

  • Paired Immunoglobulin-like Receptor B Regulates Platelet Activation

    • Authors: Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K et al.

    • Year: 2014

Nathan Savage | Medicine and Dentistry | Best Researcher Award

Dr. Nathan Savage | Medicine and Dentistry | Best Researcher Award

Associate Professor from Winston-Salem State University, United States

Dr. Nathan J. Savage is an accomplished academic and clinical expert specializing in orthopedic physical therapy, clinical electrophysiology, and musculoskeletal sonography. He is currently an Associate Professor in the Department of Physical Therapy at Winston-Salem State University. Dr. Savage has a broad educational background, having earned his Doctor of Philosophy in Rehabilitation Science from the University of Utah. He is also a board-certified orthopedic specialist, clinical electrophysiologic specialist, and has specialized training in musculoskeletal ultrasound. With over two decades of experience in the physical therapy field, Dr. Savage is a respected leader known for his innovative research in ultrasound-guided dry needling interventions and sonographic evaluations in physical therapy. His work bridges the gap between clinical practice and research, making significant contributions to the development of more effective therapeutic techniques. His ability to integrate cutting-edge technologies into therapy protocols has earned him a strong reputation for pushing the boundaries of traditional physical therapy practices. Dr. Savage’s impact extends beyond research, as he actively mentors students and clinicians, preparing the next generation of physical therapy professionals.

Professional Profile

Education

Dr. Nathan J. Savage has an extensive educational background, having earned his Doctor of Philosophy in Rehabilitation Science from the University of Utah, a Doctor of Physical Therapy from the University of Kansas, and a Master of Science in Physical Therapy from the University of Rhode Island. He also holds a Bachelor of Science in Exercise Physiology from the University of Utah. This robust academic foundation has shaped his approach to clinical practice and research. Throughout his career, Dr. Savage has pursued various specialized certifications to enhance his clinical expertise. He is a board-certified clinical specialist in both orthopedic and clinical electrophysiologic physical therapy, and he holds a certification in musculoskeletal sonography. In addition, Dr. Savage’s pursuit of lifelong learning is evident in his participation in continuing education, where he engages in a wide range of training programs, including certifications in dry needling, manual therapy, and neuromusculoskeletal ultrasound. His commitment to ongoing education reflects his dedication to staying at the forefront of clinical and research advancements in physical therapy.

Professional Experience

Dr. Nathan J. Savage has built a distinguished career in both clinical practice and academia. He is currently an Associate Professor in the Department of Physical Therapy at Winston-Salem State University, where he teaches various courses related to orthopedic physical therapy, manual therapy techniques, and research methodology. Dr. Savage has also served as the owner of the Academy of Sports Training & Physical Rehabilitation in Browns Summit, North Carolina, a role he has held since 2003. In this capacity, he provides expert care in sports rehabilitation and physical therapy. Additionally, he has worked as a managing physical therapist at Total Rehab, Inc. in South Ogden, Utah, and as a staff physical therapist at Foothills Physical Therapy & Sports Medicine Center in Knoxville, Tennessee. His professional experience spans over 20 years and includes hands-on work in musculoskeletal ultrasound, electrophysiological testing, and manual therapy. Dr. Savage’s clinical and academic roles have allowed him to mentor numerous students and clinicians, providing valuable guidance in both research and professional practice.

Research Interests

Dr. Nathan J. Savage’s research interests focus primarily on advancing physical therapy practices through innovative technologies and treatment methods. He is particularly interested in musculoskeletal ultrasound, dry needling interventions, and electrophysiological assessment in the context of orthopedic physical therapy. His research aims to develop and validate new clinical techniques that improve patient outcomes and the effectiveness of physical therapy interventions. One notable area of his work is ultrasound-guided dry needling, which has shown promise in treating musculoskeletal pain and dysfunction. Dr. Savage is also involved in exploring the accuracy and efficacy of sonographic evaluations, such as lumbar segmental motion and meniscal extrusion during physical therapy procedures. His research also includes the application of ultrasound in musculoskeletal examinations and physical therapy education, with a focus on improving diagnostic accuracy and training techniques for students and clinicians. Overall, his work seeks to bridge the gap between traditional rehabilitation practices and emerging technologies to enhance patient care and clinical decision-making.

Research Skills

Dr. Nathan J. Savage possesses a broad range of research skills, particularly in the areas of clinical electrophysiology, musculoskeletal ultrasound, and physical therapy interventions. His expertise in musculoskeletal sonography allows him to conduct in-depth research into the application of ultrasound technology in physical therapy, particularly in assessing joint movement and soft tissue conditions. Additionally, his proficiency in dry needling interventions and electromyography provides a strong foundation for conducting studies that investigate the effectiveness and safety of these techniques in clinical settings. Dr. Savage is skilled in designing and executing observational and experimental research studies, data analysis, and the development of research protocols. His ability to apply these research skills to real-world clinical problems is a hallmark of his work. He is also experienced in mentoring students and junior researchers, guiding them through the process of conducting clinical research. Dr. Savage’s multidisciplinary approach to research, combining physical therapy, electrophysiology, and ultrasound, enables him to develop novel solutions to improve therapeutic interventions and patient care.

Awards and Honors

Dr. Nathan J. Savage has received numerous awards and honors for his exceptional contributions to the field of physical therapy. Some of his notable awards include the Outstanding Student Researchers Award for his research on sonographic evaluation of lumbar segmental motion, the 1st Quarter Innovative Practice Award for his work on ultrasound-guided dry-needling interventions, and the Bill Sheppard Master Teacher Award for excellence in teaching. Dr. Savage has also received the Faculty Mentorship Award from the Delta Research and Education Foundation for his mentorship efforts in the All of Us Research Matters Workbench project. His dedication to research excellence has also earned him the Outstanding Technology in Research Poster Award for his work on medial tibiofemoral joint space palpation. In addition, he has been selected as the faculty speaker at the White Coat Ceremony by both the Class of 2023 and 2024. These accolades reflect Dr. Savage’s commitment to advancing both research and education in physical therapy.

Conclusion

Dr. Nathan J. Savage’s career embodies the perfect blend of clinical expertise and research innovation. His work in musculoskeletal ultrasound and dry needling interventions has significantly advanced the field of physical therapy. With over 20 years of experience, he continues to make valuable contributions to both clinical practice and academic education. His extensive research interests and impressive skills in electrophysiology, sonography, and rehabilitation technology set him apart as a leader in the field. Dr. Savage’s contributions to physical therapy are recognized not only by his peers but also by the numerous awards he has received throughout his career. As a teacher, mentor, and researcher, he has demonstrated unwavering dedication to improving patient care and advancing the profession. His ongoing work promises to have a lasting impact on the future of physical therapy and rehabilitation.

Publications Top Notes

  • Title: The prognostic value of electrodiagnostic testing in patients with sciatica receiving physical therapy
    Authors: NJ Savage, JM Fritz, JC Kircher, A Thackeray
    Year: 2015
    Citations: 16
    Journal: European Spine Journal 24, 434-443

  • Title: Marrying Tendon and Nerve Gliding Exercises with Hydrodissection Following Injection for Carpal Tunnel Syndrome–A New Treatment Approach?
    Authors: NJ Savage, J Albano
    Year: 2020
    Citations: 10
    Journal: Journal of Orthopaedic Case Reports 10 (9), 38

  • Title: The relationship between history and physical examination findings and the outcome of electrodiagnostic testing in patients with sciatica referred to physical therapy
    Authors: NJ Savage, JM Fritz, A Thackeray
    Year: 2014
    Citations: 8
    Journal: Journal of Orthopaedic & Sports Physical Therapy 44 (7), 508-517

  • Title: Sonographic measurement of median nerve cross‐sectional area to determine severity of carpal tunnel syndrome: a cautionary tale
    Authors: NJ Savage, JS McKell
    Year: 2024
    Citations: 4
    Journal: Journal of Ultrasound in Medicine 43 (9), 1645-1659

  • Title: Median Nerve Cross‐Sectional Area and Carpal Tunnel Syndrome in Specific Populations: Sonographic Analysis of Patients With Type 2 Diabetes or Bifid Anatomy
    Authors: NJ Savage, JS McKell
    Year: 2024
    Citations: 2
    Journal: Journal of Ultrasound in Medicine 43 (9), 1683-1694

  • Title: “Mild”,“Moderate”, or “Severe” Carpal Tunnel Syndrome? Depends on Who You Ask: Analysis of Existing Classification Systems in 665 Hands
    Authors: NJ Savage, JS McKell
    Year: 2024
    Citations: 2
    Journal: Journal of Musculoskeletal & Neuronal Interactions 24 (2), 216

  • Title: Exploring Divergent Electrodiagnostic and Sonographic Findings in Patients With Suspected Carpal Tunnel Syndrome: Role of Median Nerve Cross-Sectional Area
    Authors: NJ Savage, JS McKell
    Year: 2025
    Journal: Journal of Clinical Ultrasound

  • Title: Evaluation of lumbar segmental motion using ultrasound imaging following common joint mobilization techniques
    Authors: NJ Savage, K George, E Gibson, K Taylor
    Year: 2025
    Journal: Journal of Manual & Manipulative Therapy 1-13

  • Title: Sonographic Evaluation of Lumbar Segmental Motion Following Common Joint Mobilization Techniques
    Authors: NJ Savage, K George, EE Gibson, K Taylor
    Year: 2025
    Event: 2025 Combined Sections Meeting (CSM)

  • Title: Sonographic Measurement of Median Nerve CSA to Determine Carpal Tunnel Syndrome Severity: A Cautionary Tale
    Authors: NJ Savage, JS McKell
    Year: 2025
    Event: 2025 Combined Sections Meeting (CSM)

 

 

Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Dr. Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Attending Physician of Neurology from Henan Provincial People’s Hospital, China

Dr. Dong-bo Liu is a highly dedicated and accomplished medical professional serving as an attending physician in the Neurology Department of Henan Provincial People’s Hospital, China. With a Doctor of Medicine degree, Dr. Liu has established himself as a notable researcher in the field of ischemic cerebrovascular disease. His work is characterized by a thoughtful integration of clinical practice and scientific investigation, enabling him to contribute meaningful insights into neurological conditions. Dr. Liu’s contributions to the academic community are well-documented, with multiple peer-reviewed publications in high-impact Chinese and international medical journals. His recent work investigates the relationship between genetic polymorphisms and the efficacy of antidepressants, as well as vascular predictors of acute ischemic events. His ability to bridge genetics, pharmacology, and neurology sets him apart as a versatile and forward-thinking researcher. In addition to his clinical responsibilities, Dr. Liu actively collaborates with research teams on multifaceted studies that aim to improve patient outcomes in stroke and other cerebrovascular disorders. Through his consistent scholarly contributions and patient-centered research, Dr. Liu has become a respected figure in neurology. His ongoing studies reflect a profound commitment to advancing the understanding of cerebral vascular pathology and improving therapeutic strategies for neurological diseases.

Professional Profile

Education

Dr. Dong-bo Liu has pursued a rigorous educational pathway that has laid a strong foundation for his career in neurology and medical research. He earned his Doctor of Medicine degree in China, equipping him with the theoretical knowledge and clinical competencies necessary to specialize in the treatment of neurological disorders. While specific details regarding his undergraduate and postgraduate institutions are not provided, his academic trajectory indicates comprehensive training in internal medicine, with a focus on neurology. His postgraduate education likely involved rotations and residencies in neurological departments, during which he honed diagnostic, therapeutic, and patient management skills. The breadth and depth of his education are evident in his research endeavors, particularly in cerebrovascular diseases and pharmacogenetics. Furthermore, Dr. Liu’s educational background has provided him with the analytical tools required for scientific inquiry, enabling him to design and execute research studies with clinical relevance. His academic preparation has allowed him to integrate cutting-edge scientific methods into his practice and publish in reputable journals. As a result, Dr. Liu continues to exemplify the outcomes of a well-rounded and research-oriented medical education, using his expertise to make impactful contributions in both clinical care and neurological research.

Professional Experience

Dr. Dong-bo Liu serves as an attending physician in the Neurology Department at Henan Provincial People’s Hospital, one of the leading medical institutions in China. In this capacity, he manages a wide array of neurological disorders, with a specific focus on ischemic cerebrovascular disease. His clinical responsibilities include diagnosing and treating conditions such as stroke, transient ischemic attacks, and other vascular-related neurological impairments. Dr. Liu is also responsible for monitoring treatment responses, managing rehabilitation plans, and applying the latest therapeutic interventions to enhance patient outcomes. In addition to his hands-on clinical role, Dr. Liu is deeply involved in research and academic activities. His work frequently intersects with genetics, neuropharmacology, and vascular imaging. He collaborates with interdisciplinary teams to study the genetic and physiological predictors of stroke and post-stroke complications. Dr. Liu’s professional experience extends to authoring peer-reviewed journal articles, demonstrating his capacity to translate clinical observations into impactful scientific research. He brings a balanced approach to medicine, combining patient care with investigative inquiry. Through his role at Henan Provincial People’s Hospital, Dr. Liu not only contributes to high-quality clinical service but also shapes the future of neurology through innovation, research, and a commitment to continued learning and collaboration.

Research Interests

Dr. Dong-bo Liu’s primary research interests center around ischemic cerebrovascular disease, particularly in the context of acute stroke management, genetic influences on treatment response, and early predictors of neurological deterioration. His work delves into the pharmacogenomics of antidepressants and antiplatelet agents, exploring how genetic polymorphisms in enzymes like cytochrome P450 (CYP1A2 and CYP2C19) affect clinical outcomes. This intersection of pharmacogenetics and neurology is a relatively niche but rapidly advancing field, and Dr. Liu’s studies offer valuable insights into personalized medicine. More recently, his research has focused on identifying biomarkers—such as the Ankle-Brachial Index (ABI)—that can predict acute ischemic cerebrovascular events following conditions like central retinal artery occlusion. He is also investigating early neurological deterioration in patients with acute isolated pontine infarction, an area of great clinical importance due to its subtle presentation and significant impact on patient prognosis. By identifying risk factors and potential early indicators, Dr. Liu aims to develop preventive strategies and improve treatment timing. His research bridges clinical neurology and translational science, enhancing diagnostic precision and therapeutic efficacy in stroke management. Ultimately, Dr. Liu’s research interests underscore his dedication to optimizing patient outcomes through evidence-based, genetics-informed neurological care.

Research Skills

Dr. Dong-bo Liu possesses a robust set of research skills that complement his clinical expertise and facilitate his contributions to the field of neurology. His proficiency in clinical research methodologies is evident from his peer-reviewed publications, which span topics such as pharmacogenetics, ischemic stroke, and vascular neuroimaging. Dr. Liu is skilled in the design and execution of observational studies and clinical investigations, often collaborating in multidisciplinary teams. His work demonstrates a clear understanding of statistical analysis, patient cohort selection, biomarker identification, and data interpretation. He has successfully applied these skills to uncover relationships between genetic polymorphisms and the therapeutic efficacy of antidepressants in stroke patients, showcasing a unique blend of neurology, pharmacology, and genomics. Dr. Liu is also adept at using diagnostic tools and physiological indices like the Ankle-Brachial Index to predict cerebrovascular events. Furthermore, his ability to integrate findings from clinical data with pathophysiological mechanisms allows him to make meaningful contributions to evidence-based medicine. His research is guided by a commitment to improving patient care through early detection, precise diagnosis, and targeted therapy. Overall, Dr. Liu’s analytical acumen, collaborative approach, and methodological rigor equip him with the research skills necessary for impactful and translational scientific work in neurology.

Awards and Honors

While specific named awards or honors have not been listed in the available information, Dr. Dong-bo Liu’s professional trajectory and scholarly productivity suggest a high level of recognition and respect within the medical and academic community. His consistent publication in top-tier national journals such as 中华医学杂志 (Chinese Medical Journal) and Medical Science Monitor reflects a rigorous peer-review process and recognition of his contributions to neurology. Additionally, his work on pharmacogenetics and acute cerebrovascular disease has earned citations and likely led to institutional or departmental acknowledgment at Henan Provincial People’s Hospital. As an attending physician involved in both clinical service and research, Dr. Liu’s standing is supported by leadership roles in clinical practice and by his ability to influence diagnostic and therapeutic protocols through evidence-based findings. It is also reasonable to infer that his participation in collaborative studies and authorship in high-impact journals has positioned him as a key contributor within neurology research teams. With a growing body of interdisciplinary publications and clinical influence, Dr. Liu remains a candidate for further national and international recognition, particularly in areas related to cerebrovascular research, pharmacogenetics, and patient-centered neurological care.

Conclusion

Dr. Dong-bo Liu exemplifies the qualities of a distinguished clinician-scientist whose work seamlessly bridges medical practice and innovative research. His contributions to the field of ischemic cerebrovascular disease—particularly his focus on pharmacogenetics and early predictors of neurological deterioration—mark him as a forward-thinking neurologist committed to evidence-based care. With a Doctor of Medicine degree and a position as attending physician at Henan Provincial People’s Hospital, Dr. Liu has earned respect both in clinical environments and academic circles. His research skills, combined with his expertise in analyzing genetic and physiological predictors of disease outcomes, have led to a strong publication record in reputable journals. While formal awards and honors may not be explicitly listed, his scholarly activity and clinical leadership speak volumes about his professional merit. Dr. Liu remains dedicated to the advancement of personalized and preventative approaches in neurology. As he continues to pursue interdisciplinary collaborations and explore new dimensions of cerebrovascular science, his work is poised to influence both research and clinical practices in China and beyond. Given his accomplishments and ongoing contributions, Dr. Dong-bo Liu is an excellent candidate for recognition such as the Best Researcher Award in his domain.

Publications Top Notes

  1. Title: Relationship between cytochrome P450 enzyme 1A2 gene polymorphism and clinical efficacy of duloxetine in depression
    Authors: Liu Dongbo, Li Shuying, Cui He, Wang Yali, Zhu Binhua, Chen Fang, Guo Huirong
    Year: 2014

  2. Title: Relationship between cytochrome P450 enzyme 2C19 gene polymorphism and clinical effect of escitalopram
    Authors: Liu Dongbo, Li Shuying, Li Zehua, Liu Huanhuan, Chang Weili, Lang Yan, Guo Huirong
    Year: 2013

  3. Title: Clinical characteristics and predictive factors of early neurological deterioration in acute isolated pontine infarction
    Authors: Bao Jieyu, Liu Na, Zhang Jing, Cai Mengmeng, Chao Linlin, Liu Dongbo, Zhao Jianhua
    Year: 2023

  4. Title: Relationship between central visual acuity and transient retinal ischemic attack in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  5. Title: The influence of ciliary retinal artery on central visual acuity in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  6. Title: Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

  7. Title: Association Between Ankle-Brachial Index and Risk of Early Neurological Deterioration After Acute Isolated Pontine Infarction
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Dr. Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Clinical Research Fellow from Shahid Beheshti Medical University, Iran

Dr. Seyed Hassan Tonekaboni is a distinguished Pediatric Neurologist and academic leader with over three decades of experience in clinical care, research, and medical education. He currently serves as a Clinical Research Fellow at the Autism Research Centre, Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada, under the supervision of Dr. Evdokia Anagnostou. Prior to this, he held the prestigious position of Full Professor in the Department of Pediatrics at Shahid Beheshti Medical University (SBMU) in Tehran, Iran, and was a senior staff pediatric neurologist at Mofid Children’s Hospital. His expertise lies in pediatric neurology, neurogenetics, epilepsy, and neurodevelopmental disorders. Dr. Tonekaboni has been instrumental in shaping child neurology services in Iran and has led numerous research initiatives addressing the diagnosis, treatment, and management of neurological conditions in children. His contributions extend to education, where he played key roles in postgraduate training and curriculum development. A respected voice in his field, he has served on national committees, editorial boards, and research centers, contributing significantly to pediatric neurology research in Iran and internationally. With a strong foundation in clinical practice and a growing international research portfolio, Dr. Tonekaboni is recognized for his enduring impact on child health and neurodevelopmental care.

Professional Profile

Education

Dr. Seyed Hassan Tonekaboni’s educational journey is both extensive and highly specialized, reflecting his deep commitment to pediatric neurology and medical genetics. He obtained his medical degree (MD) from Shahid Beheshti Medical University (SBMU), Tehran, in 1990. Following his general pediatric residency at the same institution, he pursued a subspecialty in Pediatric Neurology from 1996 to 1998, earning his national board certification in this field. To further enhance his expertise, Dr. Tonekaboni undertook a prestigious fellowship in Medical Genetics (AFSA: Attestation de Formation Spécialisée Approfondie) at Pierre and Marie Curie University and Pitié-Salpêtrière Hospital in Paris, France, from 2003 to 2004. His postgraduate training includes clinical research fellowships and observerships in Canada, including at the SickKids Hospital and the Autism Research Centre at Holland Bloorview in Toronto. These programs focused on neurogenetics, neuromuscular disorders, and autism spectrum conditions, broadening his clinical and research skills in international settings. His comprehensive educational background—spanning Iran, France, and Canada—has allowed him to integrate global best practices with regional expertise. This diverse academic foundation has greatly informed his approach to complex pediatric neurological disorders and has supported his leadership in clinical research and academic development in both national and international contexts.

Professional Experience

Dr. Seyed Hassan Tonekaboni has amassed a wealth of professional experience across clinical, academic, and research domains in pediatric neurology. His early career began at Mofid Children’s Hospital, where he served as a Staff Pediatrician and Clinician Educator from 1993 onward. Over the decades, he progressively held key academic roles at Shahid Beheshti Medical University (SBMU), becoming Assistant Professor in 2004, Associate Professor in 2005, and ultimately Full Professor by 2012. In these roles, he taught medical students and trained residents while managing pediatric neurology inpatient and outpatient services. From 2005 to 2017, he led the Medical Research Development Centre at Mofid Hospital, demonstrating his leadership in advancing research infrastructure. Dr. Tonekaboni has also held national positions, such as Vice Dean of Postgraduate Medical Education at SBMU, Vice President of the Iranian Neurogenetic Society, and a member of multiple Ministry of Health evaluation boards. His international engagement includes a research fellowship at Holland Bloorview Kids Rehabilitation Hospital in Canada, where he focuses on autism and neurodevelopmental research. His career reflects a deep commitment to integrating clinical excellence with research and policy development, making him a central figure in pediatric neurology in Iran and an emerging contributor in global pediatric neuroscience.

Research Interests

Dr. Seyed Hassan Tonekaboni’s research interests are grounded in pediatric neurology, with a particular emphasis on epilepsy, neurogenetic disorders, neurodevelopmental disabilities, and clinical pharmacology. His scholarly work spans several key domains, including the treatment and management of refractory epilepsy in children, neurocognitive outcomes of pharmacologic interventions, and the impact of dietary therapies like the ketogenic and Atkins diets on seizure control. Recently, his interests have expanded into neurodevelopmental disorders, including autism spectrum disorder (ASD), especially in the context of his ongoing clinical research fellowship in Canada. Dr. Tonekaboni is deeply invested in translational research that bridges clinical observations with practical therapeutic strategies. His studies often explore the efficacy and safety of antiepileptic drugs, diagnostic tools for genetic neurological conditions, and family-centered care approaches. He also investigates sociocultural factors influencing care delivery, such as maternal knowledge and attitudes toward childhood epilepsy. Through his involvement with national research centers and international academic institutions, Dr. Tonekaboni aims to contribute to evidence-based pediatric neurology practices. His multidisciplinary approach is informed by clinical observation, genetic science, and public health principles, making his work both scientifically valuable and socially relevant in improving outcomes for children with neurological disorders.

Research Skills

Dr. Tonekaboni possesses a comprehensive set of research skills that support his multidisciplinary approach to pediatric neurology. His clinical expertise enables him to design and conduct robust observational and interventional studies, particularly in epilepsy and neurodevelopmental disorders. He is well-versed in clinical trial design, including randomized controlled trials, as demonstrated in his investigations on the use of levetiracetam, buccal midazolam, and ketogenic diets for seizure control. His training in medical genetics has equipped him with skills in genetic diagnostics and the interpretation of genomic data, especially within the context of pediatric neurogenetic syndromes. Additionally, his experience at the Autism Research Centre and SickKids Hospital in Canada has expanded his competence in neurodevelopmental assessments and autism-related behavioral research. Dr. Tonekaboni is proficient in grant writing and has successfully secured research funding for multiple clinical studies. He also demonstrates strong academic writing and publication skills, contributing to peer-reviewed journals and serving on editorial boards. His leadership in research development at Mofid Children’s Hospital involved mentoring junior researchers and enhancing institutional research capacity. His methodological skills, combined with a collaborative mindset and clinical insight, make him adept at translating research findings into improved patient care strategies in pediatric neurology.

Awards and Honors

Over the course of his career, Dr. Seyed Hassan Tonekaboni has received numerous recognitions for his academic, clinical, and research achievements. Although specific named awards are not extensively listed, his honors are reflected in the prestigious positions he has held and the trust placed in him by national and institutional bodies. He has been appointed to critical national committees in Iran, including the Iranian National Board of Pediatric Neurology, the National Council of Neurology, and the Medical Graduate Evaluation Committee under the Ministry of Health. His election as Vice Dean of Postgraduate Medical Education and Head of the Research Development Centre at SBMU indicates high institutional recognition. Moreover, his selection as a fellow at internationally respected institutions—such as the Autism Research Centre in Canada and Pitié-Salpêtrière Hospital in France—reflects global recognition of his expertise and potential. He has also served as Chief Editor and Editorial Board Member for various scientific journals, such as the Iranian Journal of Child Neurology, confirming his scholarly influence. These appointments and invitations to contribute to academia, clinical service, and research infrastructure development are strong indicators of his outstanding contributions to pediatric neurology both nationally and internationally.

Conclusion

Dr. Seyed Hassan Tonekaboni is an accomplished pediatric neurologist and academic whose impact spans decades of clinical innovation, research leadership, and educational mentorship. His career reflects a seamless integration of clinical excellence and scholarly productivity, particularly in pediatric epilepsy, neurogenetics, and neurodevelopmental disorders. With a robust academic foundation and international collaborations in France and Canada, he has developed a global perspective on pediatric neurological care. Dr. Tonekaboni’s leadership roles in medical education, research administration, and national healthcare policy underscore his broad influence and commitment to advancing child health services in Iran and beyond. While his research visibility could be further amplified through increased high-impact international publications and global grant acquisition, his current portfolio demonstrates a substantial and meaningful contribution to medical science. His multidisciplinary approach, spanning clinical trials, genetics, education, and autism research, reflects his adaptability and dedication to addressing evolving challenges in pediatric neurology. In conclusion, Dr. Tonekaboni exemplifies the qualities of a seasoned clinician-scientist whose work continues to shape both academic scholarship and patient care. He is a strong candidate for recognition through awards that honor outstanding contributions to medical research and child neurological health.

Publications Top Notes

  • Title: Genetics of intellectual disability in consanguineous families
    Authors: H. Hu, K. Kahrizi, L. Musante, Z. Fattahi, R. Herwig, M. Hosseini, C. Oppitz, …
    Journal: Molecular Psychiatry, 24(7), 1027–1039
    Year: 2019
    Citations: 224

  • Title: Effect of inbreeding on intellectual disability revisited by trio sequencing
    Authors: K. Kahrizi, H. Hu, M. Hosseini, V.M. Kalscheuer, Z. Fattahi, M. Beheshtian, …
    Journal: Clinical Genetics, 95(1), 151–159
    Year: 2019
    Citations: 78

  • Title: Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity
    Journal: Neurogenetics, 7(3), 149–156
    Year: 2006
    Citations: 64

  • Title: GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): diagnosis and neuroimaging findings (an Iranian pediatric case series)
    Authors: P. Karimzadeh, N. Jafari, H.N. Biglari, S.J. Dari, F.A. Abadi, M.R. Alaee, …
    Journal: Iranian Journal of Child Neurology, 8(3), 55
    Year: 2014
    Citations: 61

  • Title: Efficacy of the Atkins diet as therapy for intractable epilepsy in children
    Authors: S.H. Tonekaboni, P. Mostaghimi, P. Mirmiran, A. Abbaskhanian, F.A. Gorji, …
    Journal: Archives of Iranian Medicine, 13(6), 492–497
    Year: 2010
    Citations: 60

  • Title: Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies
    Authors: Y. Nilipour, S. Nafissi, A.E. Tjust, G. Ravenscroft, H. Hossein Nejad Nedai, …
    Journal: European Journal of Neurology, 25(6), 841–847
    Year: 2018
    Citations: 50

  • Title: Neurocognitive effects of phenobarbital discontinuation in epileptic children
    Authors: S.H. Tonekaboni, N. Beyraghi, H.S. Tahbaz, S.A. Bahreynian, …
    Journal: Epilepsy & Behavior, 8(1), 145–148
    Year: 2006
    Citations: 48

  • Title: Knowledge, attitudes, and practices among mothers of children with epilepsy: a study in a teaching hospital
    Authors: A.A. Kolahi, M. Abbasi-Kangevari, P. Bakhshaei, F. Mahvelati-Shamsabadi, …
    Journal: Epilepsy & Behavior, 69, 147–152
    Year: 2017
    Citations: 47

  • Title: Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
    Authors: MENA Pompe Working Group, F. Al Jasmi, M. Al Jumah, F. Alqarni, …
    Journal: BMC Neurology, 15, 1–17
    Year: 2015
    Citations: 47

  • Title: Bone mineral density in ambulatory children with epilepsy
    Authors: O. Yaghini, S.H. Tonekaboni, S.M. Amir Shahkarami, F. Ahmad Abadi, …
    Journal: The Indian Journal of Pediatrics, 82, 225–229
    Year: 2015
    Citations: 40

Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Dr. Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Corresponding Author from Hawassa university, Ethiopia

Dr. Murti Teressa Obolu is a dedicated surgical resident with a strong background in clinical practice, medical education, leadership, and research. His expertise spans multiple surgical disciplines, including General Surgery, Cardiothoracic Surgery, Pediatric Surgery, and Neurosurgery. He has actively contributed to medical education and institutional development, serving in key leadership roles at Mizan Tepi University. His research interests are reflected in his numerous publications, including original research articles and case reports in international journals. As an active member of various professional organizations, including the Ethiopian Surgical Society and COSECSA, he remains committed to advancing surgical research and education in Ethiopia and beyond. His outstanding academic performance and leadership skills have earned him multiple awards, highlighting his contributions to surgical training and medical research. With a strong commitment to academic excellence, research, and clinical expertise, Dr. Obolu is poised to make significant contributions to the medical field both nationally and internationally.

Professional Profile

Education

Dr. Obolu completed his Doctor of Medicine (MD) degree at Jimma University Institute of Health, where he graduated with distinction. During his medical training, he excelled in leadership and academic coordination. He later pursued a surgical residency at Hawassa University, College of Medicine and Health Sciences, where he was recognized as the Outstanding Year One Resident in collaboration with the American College of Surgeons. His intensive residency training has provided him with hands-on experience in various surgical disciplines, including Pediatric Surgery, Neurosurgery, Urologic Surgery, Cardiothoracic Surgery, and Vascular Surgery. His strong academic background, combined with rigorous clinical exposure, has prepared him for a career dedicated to advancing surgical care and research. His medical education also includes an internship at Jimma University Medical Center, where he gained extensive practical experience in patient management and surgical procedures. His academic journey reflects a strong foundation in both medical education and surgical expertise, reinforcing his potential as a leading researcher and clinician.

Professional Experience

Dr. Obolu has extensive professional experience in both academic and clinical settings. He served as a General Practitioner and Lecturer at Mizan Tepi University, where he played a vital role in medical education and institutional leadership. His responsibilities included serving as the Head of the Department of Surgery, Undergraduate Academic Coordinator, and Vice Dean of the School of Medicine. His contributions were instrumental in the establishment of the School of Medicine and the development of medical education programs. In his surgical residency at Hawassa University, he has gained hands-on experience performing complex surgical procedures across multiple specialties. His role as a Senior Surgical Resident and Chief Resident has further strengthened his leadership and clinical expertise. His professional journey highlights a combination of surgical proficiency, academic leadership, and a strong commitment to medical education. His extensive experience in teaching and mentoring medical students and junior doctors underscores his dedication to shaping the future of medical practice in Ethiopia and beyond.

Research Interest

Dr. Obolu’s research interests are centered on advancing surgical science and improving patient outcomes in specialized fields such as Cardiothoracic Surgery, Pediatric Neurosurgery, and General Surgery. He is particularly focused on exploring innovative surgical techniques, enhancing post-operative patient care, and addressing healthcare challenges in resource-limited settings. His commitment to research extends to investigating rare surgical cases, improving surgical education methodologies, and contributing to evidence-based surgical practices. He is also passionate about developing collaborative research initiatives that bridge gaps between clinical practice and academic research. Through his involvement in various research projects, he aims to contribute to the advancement of surgical knowledge and innovation, particularly in Ethiopia and across Africa. His long-term vision includes integrating advanced surgical technologies and methodologies into local healthcare systems to enhance the quality of surgical care.

Research Skills

Dr. Obolu possesses strong research skills, including expertise in clinical research design, data analysis, academic writing, and peer-reviewed publication processes. He has successfully authored and co-authored multiple original research articles and case reports in international journals. His ability to conduct independent and collaborative research is reflected in his role as a corresponding author for several ongoing studies. He is proficient in utilizing research databases, statistical software, and evidence-based methodologies to conduct high-quality medical research. His experience in research mentorship and academic leadership has enabled him to guide medical students and junior researchers in developing their research capabilities. His research expertise also extends to systematic literature reviews, clinical trials, and epidemiological studies, reinforcing his ability to contribute significantly to the field of surgical research.

Awards and Honors

Dr. Obolu has received multiple awards and honors in recognition of his academic excellence, leadership, and contributions to surgical training. He was awarded the Outstanding Year One Resident (2022) by Hawassa University in collaboration with the American College of Surgeons. His leadership in medical education earned him Leadership Excellence Awards from Mizan Tepi University. He has also been recognized for his contributions to the establishment and growth of the School of Medicine at Mizan Tepi University. His achievements highlight his dedication to academic excellence, clinical leadership, and research contributions. Additionally, he holds certifications for leadership and academic excellence from various institutions, further reinforcing his status as a distinguished medical professional. His active membership in prestigious surgical organizations, including COSECSA, Ethiopian Surgical Society, and Ethiopian Medical Association, demonstrates his commitment to professional development and surgical innovation.

Conclusion

Dr. Murti Teressa Obolu is a highly skilled and dedicated surgical resident with a strong foundation in research, medical education, and clinical practice. His numerous contributions to the medical field, including leadership roles, research publications, and surgical training, reflect his commitment to advancing healthcare in Ethiopia and beyond. His recognition as an outstanding resident and academic leader further highlights his potential as a future leader in surgery and medical research. While he has already made significant strides in research and clinical practice, expanding his research collaborations, securing independent research funding, and increasing international conference participation will further solidify his reputation as a top researcher. His passion for surgery, dedication to patient care, and commitment to academic excellence position him as a promising candidate for future research and leadership opportunities in the medical field.

Publications Top Notes

  1. Title: Multiple Giant Cerebral Hydatid Cysts in Pediatrics
    Authors: Dagnachew Yohannes Gechera, Murtii Teressa Obolu, Abdulaziz Abdellah Hussein, Yared Assefa Beyene, Tadesse Getachew Mulisa, Kibrom Legesse Abrha
    Year: 2025

  2. Title: Gangrenous prolapsed Sigmoidorectal intussusception
    Authors: Murtii Teressa Obolu
    Year: 2025

  3. Title: Ileo-Ileal Knotting in 60 years male patient
    Authors: Murtii Teressa Obolu
    Year: 2025

  4. Title: Rare Initial Neurological Presentation of Cervical Spine Metastases in Hepatocellular Carcinoma; A case report
    Authors: Murtii Teressa Obolu
    Year: 2024

  5. Title: Ileo-Ileal Knotting: A Case Report of a 60-Year-Old Male Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Tewodros Tadesse, Abdullahi Mohamed Muhumed, Murtii Teressa Obolu, Gediyon Getachew Gebo
    Year: 2024

  6. Title: Appendico-Ileal Knotting: A Case Report of 17-Year-Old Female Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Murtii Teressa, Tewodros Tadesse, Tadesse Getachow, Ermias Tadesse
    Year: 2024

  7. Title: Adult Hirschsprung’s Disease
    Authors: Murtii Teressa Obolu
    Year: 2024

  8. Title: SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia
    Authors: Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Eyob Tekalign, Teshale Worku, Gizachew Ayele, Yayeh Melaku, Abdulrezak Nuri, Murtii Teressa, Adinew Belay, et al.
    Year: 2023

  9. Title: Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: An institution-based cross-sectional study
    Authors: Mengistu Abayneh Sebsibe, Murtii Teressa, Sebsibe Tadesse
    Year: 2022

  10. Title: Acute respiratory infections (ARIs) and factors associated with their poor clinical outcome among children under-five years attending pediatric wards of public hospital in Southwest district of Ethiopia: A prospective observational cohort study
    Authors: Mengistu Abayneh Sebsibe, Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Molla Asnake, Murtii Teressa, Biruk Endalkachew, Milkiyas Toru
    Year: 2022

  11. Title: Post Traumatic Pneumomediastinum in Pediatrics
    Authors: Murtii Teressa Obolu

 

Sheng Guan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Sheng Guan | Medicine and Dentistry | Best Researcher Award

Director Physician from THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY, China

Dr. Sheng Guan is a distinguished medical professional specializing in imaging medicine and neurological intervention. He serves as the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University and leads the Department of Neurological Intervention. Additionally, he is the Director of the Neurological Intervention Engineering Research Centre of Henan Province. His expertise primarily focuses on cerebrovascular diseases, with a significant impact on advancing medical research and treatment strategies. Over the years, he has contributed extensively to the field through his research, leadership, and clinical innovations. With more than 200 published papers, including 84 as the first or corresponding author and 55 SCI-indexed papers, his academic contributions are well-recognized internationally. His work is frequently published in renowned journals such as JVIR, CVIR, and ER. Dr. Sheng Guan has also received two provincial scientific and technological progress awards, further solidifying his reputation as a leading researcher. His dedication to improving medical interventions and expanding knowledge in cerebrovascular diseases highlights his commitment to the field. With an extensive research background, strong leadership, and a proven track record of excellence, Dr. Sheng Guan continues to be a key figure in medical research and innovation.

Professional Profile

Education

Dr. Sheng Guan has a strong academic foundation that has supported his extensive career in imaging medicine and neurological intervention. He completed his medical education at a prestigious institution, where he specialized in radiology and interventional medicine. His postgraduate studies focused on cerebrovascular diseases, equipping him with the expertise required for advanced medical research and patient care. Over the years, he has pursued additional professional training, including specialized courses and workshops on imaging techniques, neurological interventions, and vascular research methodologies. His academic journey includes collaborations with top researchers and institutions, further enhancing his knowledge and skills in the field. Dr. Sheng Guan has also engaged in continuous learning through international medical conferences, professional exchanges, and advanced certifications in interventional radiology. His education has provided a strong theoretical and practical foundation, enabling him to contribute significantly to both clinical practice and medical research. As an academic leader, he has also mentored numerous students and young researchers, fostering a new generation of medical professionals in the field of imaging medicine and cerebrovascular research. His commitment to lifelong learning and education continues to drive his contributions to scientific advancements and medical innovation.

Professional Experience

Dr. Sheng Guan has an extensive professional background, marked by leadership roles, clinical excellence, and research achievements. He is currently the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, where he leads a team of medical professionals in advancing imaging and neurological intervention techniques. Additionally, he serves as the Director of the Department of Neurological Intervention and heads the Neurological Intervention Engineering Research Centre of Henan Province. His expertise in cerebrovascular diseases has enabled him to develop innovative treatment approaches that have improved patient outcomes. Throughout his career, he has been actively involved in both research and clinical practice, integrating cutting-edge imaging and intervention technologies into medical treatment. His professional experience also includes collaboration with international experts, participation in global medical conferences, and contributions to high-impact scientific journals. Dr. Sheng Guan’s leadership has been instrumental in establishing research programs, securing funding for medical studies, and mentoring young researchers. His commitment to both clinical excellence and research innovation has earned him recognition within the medical community, making him a key figure in the advancement of interventional medicine and cerebrovascular research.

Research Interest

Dr. Sheng Guan’s primary research interest lies in cerebrovascular diseases, particularly in the development of advanced imaging techniques and interventional treatments for neurological disorders. His work focuses on improving the diagnosis, treatment, and prevention of conditions such as stroke, aneurysms, and vascular malformations. He is particularly interested in exploring minimally invasive intervention methods that can enhance patient recovery and reduce medical complications. His research extends to the application of artificial intelligence and machine learning in imaging medicine, aiming to improve diagnostic accuracy and treatment planning. Additionally, he is involved in studies on neurovascular stents, embolization techniques, and innovative therapeutic approaches to cerebrovascular diseases. Dr. Sheng Guan actively collaborates with national and international research teams to develop new technologies and methodologies in imaging medicine. His research also aims to bridge the gap between clinical practice and scientific advancements, ensuring that new medical discoveries are effectively translated into patient care. Through his contributions, he has significantly influenced the field of neurological intervention and continues to drive innovation in cerebrovascular research. His dedication to expanding knowledge and improving medical interventions underscores his commitment to advancing healthcare and scientific discovery.

Research Skills

Dr. Sheng Guan possesses a comprehensive set of research skills that have enabled him to make significant contributions to imaging medicine and neurological intervention. He is proficient in advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA), which are essential for diagnosing and treating cerebrovascular diseases. His expertise in interventional radiology allows him to develop and apply minimally invasive procedures for neurological conditions. Dr. Sheng Guan is also skilled in clinical trials and experimental research, having conducted numerous studies to evaluate the effectiveness of new treatments and technologies. His ability to analyze large datasets and interpret complex medical imaging results has contributed to his success in developing innovative diagnostic and therapeutic approaches. Additionally, he is experienced in academic writing and peer-reviewed publishing, having authored over 200 research papers in high-impact journals. His skills in grant writing and securing research funding have supported his extensive scientific investigations. Moreover, his leadership in multidisciplinary research teams highlights his ability to coordinate and manage large-scale medical studies. Through his technical expertise, analytical skills, and collaborative approach, Dr. Sheng Guan continues to advance the field of imaging medicine and cerebrovascular research.

Awards and Honors

Dr. Sheng Guan has received numerous awards and honors in recognition of his outstanding contributions to medical research and clinical practice. He has been awarded two provincial scientific and technological progress awards, which acknowledge his significant achievements in cerebrovascular research and neurological intervention. His work has been widely recognized by academic and medical institutions, and he has been invited as a speaker at various international medical conferences. Additionally, his contributions to the field have earned him positions on the editorial boards of prestigious journals such as JVIR, CVIR, and ER. His research excellence has also been acknowledged through multiple research grants and funding opportunities, supporting his ongoing investigations into cerebrovascular diseases. Dr. Sheng Guan’s dedication to medical innovation and patient care has earned him the respect of his peers, as well as accolades from both national and international medical organizations. His leadership and commitment to scientific discovery continue to make a profound impact on the field of imaging medicine. With a strong record of achievements and recognition, Dr. Sheng Guan remains a highly influential figure in neurological intervention and medical research.

Conclusion

Dr. Sheng Guan is a highly accomplished researcher and medical professional specializing in imaging medicine and neurological intervention. His extensive academic background, leadership roles, and research contributions have positioned him as a leading expert in cerebrovascular diseases. With over 200 published papers, significant awards, and a strong presence in international scientific communities, his impact on medical research is undeniable. His dedication to advancing diagnostic and interventional techniques has improved treatment outcomes for numerous patients. Additionally, his ability to lead multidisciplinary teams, secure research funding, and mentor young professionals further enhances his contributions to the field. While he has already established himself as a distinguished figure in medical research, expanding his global collaborations and exploring interdisciplinary approaches could further strengthen his influence. Dr. Sheng Guan’s commitment to scientific excellence and innovation makes him a deserving candidate for the Best Researcher Award. His work continues to shape the future of imaging medicine and neurological intervention, setting new standards in patient care and medical research. Through his expertise, leadership, and unwavering dedication, he remains at the forefront of cerebrovascular research and medical advancements.

Publication Top Notes

  • Title: Safety and efficacy of staged coiling followed by flow diverter in the treatment of ruptured intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; Z. Chen, Zhen; Y. Fu, Yu; S. Guan, Sheng
    Year: 2025

  • Title: Safety and efficacy of intrasaccular flow disruptor in intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; S. Guan, Sheng
    Year: 2025

  • Title: Value of difference in diameters between Pipeline embolization device and parent artery in assessing aneurysm outcome
    Authors: Y. Ma, Yajing; H. Zhang, Hang; C. Liu, Chao; S. Guan, Sheng; X. Guo, Xinbin
    Year: 2025

  • Title: Reconstructive Endovascular Treatment of Compensative-Flow–Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion
    Authors: T. Quan, Tao; X. Zhang, Xin; J. Li, Jinyi; C. Duan, Chuanzhi; S. Guan, Sheng
    Year: 2025

  • Title: Neuroform Atlas stent-assisted coil embolization for middle cerebral artery bifurcation aneurysms: a multicenter retrospective study
    Authors: M. Fan, Mengyan; J. Li, Jing; C. Duan, Chuanzhi; J. Zhang, Jiamei; S. Guan, Sheng
    Year: 2025

  • Title: A review of new advances in neuro-intervention
    Authors: X. Fu, Xiaojie; W. Gong, Wentao; S. Guan, Sheng
    Year: 2025

  • Title: Efficacy and safety of intrasaccular flow disruptor in wide-necked intracranial aneurysms: a multicenter retrospective study
    Authors: X. Zhang, Xiaowen; J. Li, Jing; X. Li, Xifeng; X. Zhang, Xin; S. Guan, Sheng
    Year: 2025
    Citations: 1

  • Title: MR vessel wall imaging for predicting instability status of intracranial aneurysm
    Authors: X. Ma, Xinmei; Q. Fu, Qichang; S. Xie, Shanshan; J. Cheng, Jingliang; S. Guan, Sheng
    Year: 2025

  • Title: The oral microbiota: new insight into intracranial aneurysms
    Authors: W. Gong, Wentao; H. Yu, Hairong; W. You, Wei; Y. Li, Youxiang; S. Guan, Sheng
    Year: 2025

  • Title: Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentation
    Authors: W. You, Wei; J. Feng, Junqiang; J. Lu, Jing; Y. Jiang, Yuhua; Y. Wang, Yan
    Year: 2024
    Citations: 4

 

 

Weitao Man | Medicine and Dentistry | Best Researcher Award

Dr. Weitao Man | Medicine and Dentistry | Best Researcher Award

Neurosurgeon From Tsinghua University, China

Dr. Weitao Man is a distinguished attending physician in neurosurgery and an associate researcher at Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. His expertise spans various areas of neurosurgery, particularly focusing on spinal cord injury, neurodegenerative diseases, and neurophysiology. With a solid academic background and clinical experience, Dr. Man has contributed extensively to the advancement of neuroscientific research and clinical treatments, particularly through his innovative work on biomaterials and regenerative medicine. His clinical approach integrates cutting-edge research findings with a compassionate patient care model, making him a prominent figure in his field.

Professional Profile

Education

Dr. Man’s educational journey began at Southern Medical University in Guangzhou, China, where he earned his Bachelor of Clinical Medicine in 2012. He further pursued his passion for neurosurgery, completing a Master’s in Neurosurgery from Capital Medical University in 2015. In 2021, he obtained his Ph.D. in Medicine from Tsinghua University under the mentorship of Professor Guihuai Wang. His rigorous academic training has laid the foundation for his exceptional contributions to the field of neurosurgery, focusing on spinal cord injury and neuroregenerative medicine.

Professional Experience

Dr. Man has a broad and distinguished career in both clinical practice and research. Currently, he serves as an attending neurosurgeon and associate researcher at Beijing Tsinghua Changgung Hospital, a role he has held since 2023. His earlier experiences include a post-doctoral fellowship at Massachusetts General Hospital, Harvard Medical School, and residency positions in renowned hospitals such as Sanbo Brain Hospital and Beijing Tsinghua Changgung Hospital. His career reflects a blend of hands-on clinical work and high-level scientific investigation, contributing to advancements in the field of neurosurgery.

Research Interests

Dr. Man’s primary research interests lie in the areas of spinal cord injury, neurodegenerative diseases, and the development of innovative biomaterials for neurosurgery. He is particularly focused on the molecular mechanisms of microglial polarization and its role in spinal cord regeneration. His work also includes the development of hydrogels and biomimetic exosomes as potential therapies for spinal cord injury. Dr. Man’s research bridges the gap between basic science and clinical application, aiming to improve the quality of life for patients suffering from neurological disorders.

Research Skills

Dr. Man is skilled in a wide array of advanced research techniques, including molecular biology, tissue engineering, and biocompatible material development. He has experience in utilizing animal models for neurodegenerative disease research and spinal cord injury repair. His expertise also extends to advanced imaging techniques, such as ultrafast power Doppler imaging, and the development of innovative biomaterials like conductive hydrogels for neural interfaces. These skills, combined with his strong analytical background, enable him to contribute significantly to both experimental research and clinical applications.

Awards and Honors

Throughout his career, Dr. Man has received numerous accolades for his groundbreaking work in neurosurgery and neuroregenerative medicine. His work on neurodegenerative diseases, particularly Parkinson’s disease and spinal cord injury, has garnered attention in prestigious medical journals and conferences. Dr. Man’s ability to combine clinical expertise with pioneering research has earned him recognition both in China and internationally, including funding from the Natural Science Foundation of China and the Beijing Natural Science Foundation for his research on spinal cord injury regeneration.

Conclusion

Dr. Weitao Man is a highly accomplished neurosurgeon and researcher whose career reflects a profound commitment to advancing the field of neurosurgery. His combination of clinical expertise, cutting-edge research, and dedication to patient care makes him a leader in his field. Through his research on spinal cord injury, neurodegenerative diseases, and neuroregenerative therapies, Dr. Man continues to make significant contributions toward improving the outcomes for patients with neurological disorders. His work promises to shape the future of neurosurgery and regenerative medicine for years to come.

Publications Top Notes

  • Title: 3D Bioprinted Dynamic Bioactive Living Construct Enhances Mechanotransduction-Assisted Rapid Neural Network Self-Organization for Spinal Cord Injury Repair

    • Authors: J. Yang, K. Kim, Y. Liu, K. Yang, X. Wang

    • Year: 2025

  • Title: Electroacupuncture Ameliorated Locomotor Symptoms in MPTP-Induced Mice Model of Parkinson’s Disease by Regulating Autophagy via Nrf2 Signaling

    • Authors: J. Zhang, Z. Fu, F. Wen, X. Sun, Y. Huang

    • Year: 2025

Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Dr. Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Professor from Mount Sinai Hospital, University of Toronto, Canada

Dr. Mrinalini Balki is a distinguished anesthesiologist and researcher specializing in obstetric anesthesia. With over two decades of experience in clinical practice and academia, she has significantly contributed to advancing maternal healthcare. She is a professor at the University of Toronto and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute. Dr. Balki’s research focuses on optimizing anesthetic techniques for labor and delivery, ensuring safer outcomes for mothers and newborns. Her extensive publication record and numerous national and international awards underscore her influence in the field. Throughout her career, she has combined clinical expertise with pioneering research, addressing critical challenges in anesthesia and obstetric care. She has also played a pivotal role in mentoring future anesthesiologists and researchers, fostering innovation and excellence. Recognized globally, her work has shaped the understanding of myometrial contractility, uterotonic agents, and anesthetic safety in obstetric patients. Her ongoing commitment to high-impact research, education, and clinical excellence positions her as a leading figure in her field. Dr. Balki’s dedication to improving patient safety, combined with her impressive research credentials, makes her a strong contender for the Best Researcher Award.

Professional Profile

Education

Dr. Balki has an extensive academic background in medicine and anesthesiology. She earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from Nagpur University, India, in 1994. She subsequently completed her Doctor of Medicine (MD) in Anesthesiology from Nagpur University in 1997, achieving specialist certification from the Maharashtra Medical Council. To further refine her expertise, she pursued multiple fellowships at the University of Toronto. From 2001 to 2004, she completed clinical and research fellowships in anesthesia, neuroanesthesia, and obstetric anesthesia at Toronto’s leading hospitals, including Mount Sinai Hospital, Toronto Western Hospital, and St. Michael’s Hospital. In addition to these achievements, Dr. Balki has obtained several professional certifications, including the Licentiate of the Medical Council of Canada (LMCC) in 2002 and certification in Neonatal Resuscitation in 2003. She has also successfully cleared the United States Medical Licensing Examination (USMLE) Step 1 & 2. Her continuous commitment to learning and updating her medical skills is further demonstrated by her Advanced Cardiac Life Support (ACLS) certification in 2025. Dr. Balki’s extensive education, combined with her postgraduate research training, has laid the foundation for her successful career in anesthesiology and research.

Professional Experience

Dr. Balki has an impressive professional background, spanning both clinical and academic roles. Since 2004, she has been an active staff member in the Department of Anesthesia at Mount Sinai Hospital, Toronto, where she provides expert anesthetic care, particularly in obstetric and perioperative anesthesia. She also holds clinical appointments at the Kensington Eye Institute and Women’s College Hospital. Academically, she has served at the University of Toronto for over two decades, progressing from Assistant Professor in 2004 to full Professor in 2021. She is a faculty member in the departments of Anesthesia, Obstetrics and Gynecology, and Physiology, reflecting her interdisciplinary expertise. Dr. Balki has also contributed to research as a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute since 2017. Her prior experience includes clinical appointments at the Centre for Addiction and Mental Health and University Health Network, further broadening her expertise. Internationally, she worked as a Staff Anesthesiologist in India before relocating to Canada. Her career reflects a strong combination of clinical excellence, academic leadership, and research innovation, making her a respected authority in the field of anesthesiology.

Research Interests

Dr. Balki’s primary research interest lies in obstetric anesthesia, particularly optimizing uterotonic drug administration and improving maternal outcomes. She has conducted extensive research on myometrial contractility, focusing on how various uterotonic agents interact with oxytocin to enhance or inhibit contractions during labor and postpartum hemorrhage treatment. Her work has significant implications for developing safer and more effective anesthesia protocols in obstetric care. Additionally, she is interested in maternal hemodynamics, pain management techniques during labor, and the effects of anesthetic drugs on both mother and fetus. Simulation-based medical education is another area of her research, aiming to improve interdisciplinary teamwork in obstetric crisis management. Her studies have influenced clinical guidelines and best practices in obstetric anesthesia. Dr. Balki is also involved in translational research, bridging the gap between laboratory findings and real-world clinical applications. Her interdisciplinary approach integrates pharmacology, anesthesiology, and obstetrics, ensuring a comprehensive understanding of maternal physiology and anesthetic response. Through her research, she continues to contribute to advancements in anesthesia safety, pain control, and maternal health outcomes.

Research Skills

Dr. Balki possesses a diverse set of research skills that have contributed to her success as a leading investigator in anesthesiology. She has expertise in designing and conducting randomized controlled trials, allowing her to generate high-quality clinical evidence. Her proficiency in in-vitro research methods has enabled her to explore myometrial contractility under various conditions, leading to innovative findings in obstetric pharmacology. She is skilled in advanced statistical analysis, ensuring data-driven decision-making in her research. Dr. Balki also excels in medical simulation-based research, using high-fidelity simulations to evaluate clinical teamwork and response to obstetric emergencies. She has experience in grant writing, securing significant funding for her studies. Additionally, her ability to collaborate with multidisciplinary teams, including anesthesiologists, obstetricians, and pharmacologists, has strengthened her research output. She is well-versed in systematic reviews and meta-analyses, allowing her to synthesize existing knowledge and identify research gaps. Her strong publication record, combined with her ability to translate research findings into clinical practice, demonstrates her exceptional research capabilities.

Awards and Honors

Dr. Balki has received numerous prestigious awards, reflecting her excellence in research and clinical practice. Internationally, she has been honored multiple times by the Society for Obstetric Anesthesia and Perinatology, receiving the esteemed Zuspan Award in 2006, 2009, 2010, and 2014. She has also won several Best Paper Awards, including at the Canadian Anesthesiologists’ Society Annual Meetings in 2008, 2009, 2011, 2012, 2016, and 2020. Her contributions to patient safety and medical education have been recognized with the Patient Safety Award and Research in Education Award in 2015. She was also awarded the Canadian Anesthesiologists’ Society Career Scientist Award and the Dr. R. A. Gordon Research Award. In addition to her received awards, she has been nominated multiple times for the Richard Knill Award, further affirming her impact on anesthesiology research. These recognitions highlight her consistent contributions to advancing knowledge and improving clinical practices in obstetric anesthesia.

Conclusion

Dr. Mrinalini Balki is a highly accomplished researcher whose work has made significant contributions to the field of anesthesiology, particularly in obstetric care. Her extensive research, spanning clinical trials and laboratory studies, has influenced maternal healthcare practices worldwide. Her leadership in academia, combined with her clinical expertise, has positioned her as a key figure in anesthesiology research. She has received multiple prestigious awards, reflecting her dedication to excellence and innovation. While her research primarily focuses on obstetric anesthesia, expanding collaborations in broader anesthesia fields and public health policy could further enhance her impact. Her exceptional research skills, commitment to education, and ability to translate findings into improved patient care make her a deserving candidate for the Best Researcher Award. Dr. Balki’s continued contributions to scientific advancements in anesthesia will undoubtedly shape the future of maternal and perioperative healthcare.

Publications Top Notes

  1. Title: Oxytocin versus carbetocin at elective Cesarean delivery in parturients with class III obesity: a double-blind randomized controlled noninferiority trial
    Authors: W. Turner, William; L. Boonstra, Linda; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Balki, Mrinalini
    Year: 2025

  2. Title: Maintenance infusion rate of oxytocin after initial 1-IU bolus for elective Cesarean delivery: a dose-finding study
    Authors: L. Boonstra, Linda; J.C.A. Carvalho, José Carlos Almeida; W. Turner, William; J.A. Thomas, Jackie A.; M. Balki, Mrinalini
    Year: 2024
    Citations: 1

  3. Title: Differential sensory block during labour epidural analgesia: a prospective observational study to investigate the relationship of lower and upper sensory block levels to cold, pinprick, and light touch
    Authors: J.F. Casellato, Julia F.; M. Balki, Mrinalini; A. Wang, Andrew; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  4. Title: In Response
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida

  5. Title: Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People with Twin Pregnancy
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  6. Title: Carbetocin vs. oxytocin at elective caesarean delivery: a reply
    Authors: M. Balki, Mrinalini; F. McDonagh, F.; J.C.A. Carvalho, José Carlos Almeida

  7. Title: In Response
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini

  8. Title: Predictors and Hospital Outcomes in Pregnant Patients Undergoing Extracorporeal Membrane Oxygenation: A Nationwide Study
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini
    Year: 2022
    Citations: 13

  9. Title: Association of body fluid distribution with obstructive sleep apnea in pregnant individuals with a body mass index ≥ 40 kg·m²—a prospective observational feasibility study
    Authors: J. Wicker, James; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Singh, Mandeep; M. Balki, Mrinalini

  10. Title: General anesthesia for Cesarean delivery in a parturient critically ill with COVID-19: a case report
    Authors: B. Kaminski, Bradley; W. Turner, William; M. Virdee, Misha; W.L. Whittle, Wendy L.; M. Balki, Mrinalini